Archive

Perspectives in Primary Care features writing from practitioners, activists, and community members representing organizations, practices, and institutions across the United States and around the world.

Insights

Wellness for Everybody—in Every Body

In recent years, several qualitative studies have given us field notes of patients describing their experiences having larger bodies and interacting with the health care system: “I think that medical professionals will often cut people off about other medical concerns and blame everything on being overweight. Patients need to have their other ...
Reference

Glucagon-Like Peptide-1 Receptor Agonists: A Pharmacy Perspective on Insurance Coverage and Medication Access

Glucagon-like peptide-1 receptor agonists, more commonly referred to as GLP-1s, have undoubtedly garnered much fanfare the past five years. This class of medications is prescribed for many indications including diabetes, weight loss, and to reduce the risk of heart attack and stroke in adults with heart disease. The first GLP-1, Byetta (exenatide), was approved by the Food and Drug Administration (FDA) in 2005 to treat diabetes mellitus Type 2. It was not until 2014 that the first GLP-1 was ...
Reference

Update in Weight Management within Primary Care in the Era of GLP-1

Note: this piece is an update to the 2024 article Integrating Weight Management in Primary Care, published in this journal, which outlined practical methods to initiating and monitoring patient-centered weight management in a primary care setting. This article specifically addresses the use of GLP-1 and GIP receptor agonists. The availability and increasing popularity of glucagon-like peptide-1 (GLP-1) ...